NCT00940121View on ClinicalTrials.gov

Pharmacokinetics of Oral Mirabegron With Different Release Rates Versus Intravenous (IV) Mirabegron

PHASE1CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

July 13, 2009

Study Completion Date

July 13, 2009

Conditions
HealthyPharmacokinetics of Mirabegron
Interventions
DRUG

mirabegron

oral tablet

DRUG

mirabegron

IV solution

Trial Locations (1)

98418

Tacoma

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY